VPAResearch: Market Research Reports

Genital Herpes Pipeline Overview The Q4 Genital Herpes pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under developme...

Gonorrhea Pipeline Overview The Q4 Gonorrhea pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Gon...

Granulomatosis with Polyangiitis Pipeline Overview The Q4 Granulomatosis with Polyangiitis pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the p...

Grass Pollen Allergy Pipeline Overview The Q4 Grass Pollen Allergy pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs under d...

Haemophilus influenzae Type B Infections Pipeline Overview The Q4 Haemophilus influenzae Type B Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly re...

Hand, Foot and Mouth Disease Pipeline Overview The Q4 Hand, Foot and Mouth Disease pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipel...

Hepatitis A Pipeline Overview The Q4 Hepatitis A pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for...

Hepatitis C (HCV) Pipeline Overview The Q4 Hepatitis C (HCV) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under dev...

Hepatitis D Pipeline Overview The Q4 Hepatitis D pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for...

Hereditary Angioedema Pipeline Overview The Q4 Hereditary Angioedema pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs under...

Herpes Labialis (Oral Herpes) Pipeline Overview The Q4 Herpes Labialis (Oral Herpes) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pip...

Herpes Zoster (Shingles) Pipeline Overview The Q4 Herpes Zoster (Shingles) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of d...

Heterozygous familial hypercholesterolemia (heFH) Pipeline Overview The Q4 Heterozygous familial hypercholesterolemia (heFH) pipeline report is part of the VPA Metabolic Disorder disease pipeline serv...

Hospital Acquired Methicillin Resistant Staphylococcus aureus (HA-MRSA) Infections Pipeline Overview The Q4 Hospital Acquired Methicillin Resistant Staphylococcus aureus (HA-MRSA) Infections pipeline...

Hospital Acquired Pneumonia (HAP) Pipeline Overview The Q4 Hospital Acquired Pneumonia (HAP) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes...

House Dust Mite Allergy Pipeline Overview The Q4 House Dust Mite Allergy pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs u...

Hyperglycemia Pipeline Overview The Q4 Hyperglycemia pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the pipeline of drugs under develop...

Hyperinsulinemia Pipeline Overview The Q4 Hyperinsulinemia pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the pipeline of drugs under d...

Hypoglycemia Pipeline Overview The Q4 Hypoglycemia pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the pipeline of drugs under developme...

Impetigo Pipeline Overview The Q4 Impetigo pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Impet...

Influenza A H5N1 Infection Pipeline Overview The Q4 Influenza A H5N1 Infection pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline...

Influenza A H7N9 Infection Pipeline Overview The Q4 Influenza A H7N9 Infection pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline...

Influenza A Virus H3N2 Subtype Infections Pipeline Overview The Q4 Influenza A Virus H3N2 Subtype Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly...

Influenza B Infections Pipeline Overview The Q4 Influenza B Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs...

Insulin Resistance Pipeline Overview The Q4 Insulin Resistance pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the pipeline of drugs und...

Japanese Encephalitis Pipeline Overview The Q4 Japanese Encephalitis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs u...

Kaposi Sarcoma Pipeline Overview The Q4 Kaposi Sarcoma pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under developme...

Kidney Transplant Rejection Pipeline Overview The Q4 Kidney Transplant Rejection pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of...

Klebsiella pneumoniae Infections Pipeline Overview The Q4 Klebsiella pneumoniae Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes t...

Lassa Fever Pipeline Overview The Q4 Lassa Fever pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for...

Leishmaniasis (Kala-Azar) Pipeline Overview The Q4 Leishmaniasis (Kala-Azar) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of...

Liver Transplant Rejection Pipeline Overview The Q4 Liver Transplant Rejection pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of d...

Lung Transplant Rejection Pipeline Overview The Q4 Lung Transplant Rejection pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of dru...

Lyme Disease Pipeline Overview The Q4 Lyme Disease pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development f...

Marburgvirus Infections Pipeline Overview The Q4 Marburgvirus Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of dru...

Measles Pipeline Overview The Q4 Measles pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Measles...

Meningitis Pipeline Overview The Q4 Meningitis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for M...

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections Pipeline Overview The Q4 Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections pipeline report is part of the VPA 110 Infectio...

Microscopic Polyangiitis (MPA) Pipeline Overview The Q4 Microscopic Polyangiitis (MPA) pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipel...

Middle East Respiratory Syndrome (MERS) Pipeline Overview The Q4 Middle East Respiratory Syndrome (MERS) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly revi...

Mumps Pipeline Overview The Q4 Mumps pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Mumps, prov...

Myasthenia Gravis Pipeline Overview The Q4 Myasthenia Gravis pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs under develop...

Neisseria meningitidis Infections Pipeline Overview The Q4 Neisseria meningitidis Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes...

Onychomycosis (Tinea Unguium) Pipeline Overview The Q4 Onychomycosis (Tinea Unguium) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pip...

Osteomyelitis Pipeline Overview The Q4 Osteomyelitis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development...

Peanut Allergy Pipeline Overview The Q4 Peanut Allergy pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs under development f...

Pemphigus Vulgaris Pipeline Overview The Q4 Pemphigus Vulgaris pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs under devel...

Pertussis (Whooping Cough) Pipeline Overview The Q4 Pertussis (Whooping Cough) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline...

Phenylketonuria (PKU) Pipeline Overview The Q4 Phenylketonuria (PKU) pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the pipeline of dru...

Pituitary ACTH Hypersecretion Pipeline Overview The Q4 Pituitary ACTH Hypersecretion pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the...